Stock Markets February 19, 2026

S&P Moves PTT Global Chemical Outlook to Negative, Cites Prolonged Petrochemical Downturn

Credit rating affirmed at 'BBB-' as weak earnings, restructuring costs and overcapacity weigh on recovery prospects through 2027

By Jordan Park
S&P Moves PTT Global Chemical Outlook to Negative, Cites Prolonged Petrochemical Downturn

S&P Global Ratings has shifted the outlook on PTT Global Chemical (PTT GC) to negative from stable while keeping the issuer credit rating at 'BBB-'. The agency pointed to a sustained industry downturn, weak 2025 results with adjusted debt-to-EBITDA of about 9x, and structural overcapacity that will delay material improvement in credit metrics until at least 2027. GC's deleveraging is expected to rely heavily on a THB30 billion asset monetization plan and continued financial support from parent PTT.

Key Points

  • S&P revised PTT Global Chemical's outlook to negative from stable while affirming the 'BBB-' rating.
  • GC reported weaker-than-expected 2025 results with adjusted debt-to-EBITDA of about 9x; S&P forecasts EBITDA of about THB26 billion in 2026.
  • GC will rely on a THB30 billion asset monetization plan and potential drawdowns from a PTT trade credit facility (THB20 billion-THB25 billion) to address refinancing and deleveraging needs.

S&P Global Ratings has revised the outlook for PTT Global Chemical - known as GC - to negative from stable, even as it affirmed the company's long-term issuer credit rating at 'BBB-'. The ratings agency flagged an extended downturn in the petrochemical sector that it says will postpone a meaningful recovery in GC's credit metrics.

S&P does not expect a material earnings turnaround for GC until at least 2027 and projects that the company's leverage will likely remain elevated in the 6.5x-7.5x range over the same period.

GC's full-year 2025 performance missed S&P's expectations, producing an adjusted debt-to-EBITDA ratio of roughly 9x. The rating agency attributed the weaker results to compressed product spreads and reduced sales volumes, the latter partly driven by planned maintenance at GC's refinery and its aromatics plant. Additionally, the ongoing restructuring of subsidiary Vencorex contributed to operating losses of nearly THB2 billion.

In response to these trends, S&P lowered its business risk assessment for GC. The agency cited persistent structural overcapacity in the global petrochemical market that it expects will continue to impair profitability over the next two to three years. The commissioning of larger, lower-cost petrochemical capacity in China and the Middle East has eroded GC's competitiveness in commodity chemical segments.

Over the last four to five years, GC's EBITDA margins have been depressed at approximately 3%-5%, a performance S&P said is weaker than that of global peers with comparable business risk assessments.

Looking forward, S&P projects GC's EBITDA to be about THB26 billion in 2026, a figure that is 25% lower than the agency's prior forecast. That projection incorporates expectations for somewhat higher petrochemical and refined fuel sales volumes over the next 12 months, supported in part by cheaper Gulf gas feedstock under Thailand's revised gas prices that took effect in January 2026.

Given constrained free operating cash flow under current market conditions, S&P anticipates GC will increasingly rely on a THB30 billion asset monetization plan to pay down debt. GC expects THB9 billion of that program to be completed in the first quarter of 2026, with the remaining THB20 billion to be delivered through several transactions.

The ratings agency also noted that continued financial support from parent company PTT will help underpin GC's credit profile. S&P estimates GC can access an additional THB20 billion-THB25 billion from an extended trade credit facility with PTT, which should assist in meeting refinancing needs through at least 2027.

S&P's change to a negative outlook reflects its assessment that persistent weakness in the petrochemical industry casts uncertainty over GC's deleveraging path during the next 12-24 months. That uncertainty increases the imperative for GC to adhere to plans to reduce leverage toward a 5x debt-to-EBITDA target and to successfully execute its asset monetization initiatives.


Clear summary

S&P has moved GC's outlook to negative while affirming a 'BBB-' rating, citing prolonged industry weakness, weak 2025 results with adjusted debt-to-EBITDA about 9x, structural overcapacity and the need for asset sales and parental support to reach deleveraging targets by 2027.

Risks

  • Persistent industry weakness and structural overcapacity in petrochemicals could delay profitability recovery and keep leverage elevated - impacting the petrochemicals and energy sectors.
  • Execution risk around GC's THB30 billion asset monetization plan and its ability to complete THB9 billion in Q1 2026 and the remaining THB20 billion - relevant to capital markets and creditors.
  • Uncertainty over volume and margin recovery due to competition from lower-cost petrochemical capacity in China and the Middle East - affecting commodity chemical producers and related supply chains.

More from Stock Markets

WarrenAI Ranks Five Solar Stocks Poised for Diverse Risk-Reward Profiles in 2026 Feb 20, 2026 U.S. Equities Close Higher as Consumer Services, Tech and Telecoms Lead Gains Feb 20, 2026 Electra Battery Materials Upsizes ATM to $25M; Shares Slip After Hours Feb 20, 2026 Mexican equities close higher as industrial and consumer sectors lead gains Feb 20, 2026 Toronto Market Hits Record as Materials and Tech Drive Gains Feb 20, 2026